Researchers at Fribourg University have found a gene which is capable of preventing the growth of colon cancers.
The gene is activated by non-steroid anti-inflammatory drugs such as aspirin and could lead to the development of new prevention measures for colon cancer. It works by forcing malignant tumor cells to become more benign.
Results of the research undertaken by a team led by Professor Curzio Rüegg were published in leading international cancer journal Oncogene.
Epidemiological studies showed that regular use of non-steroid anti-inflammatory drugs over several years significantly reduced the risk of developing certain tumors.
However, prescription of these drugs in general terms for cancer prevention is not recommended given side effects such as ulcers. Researchers aim to look for ways to mimic the effects of non-steroid anti-inflammatory drugs without the side effects.
In compliance with the JTI standards